Petco Health and Wellness Company, Inc. (WOOF) SEC Filings & Earnings Calls
EquiReason read 17 Petco Health and Wellness Company, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-09-04 — Q3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%..
Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason
- Market cap
- 794.3M
- P/E TTM
- 24.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
4 Sep 202610-QQ3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2026 | $1.49B | +0% y/y |
| Comparable sales change · Q3-2026 | 0.6% | |
| Adjusted EBITDA · Q3-2026 | $122M | +7% y/y |
| Gross profit rate · Q3-2026 | 39.7% | |
| Net income attributable to Class A and B-1 common stockholders · Q3-2026 | $39M | +177% y/y |
| Free Cash Flow · H1-2026 | $61M | +513% y/y |
| Operating cash flow · H1-2026 | $131M | +85% y/y |
| Total pet care centers (U.S.) at end of period · Q3-2026 | 1,377 | -1% y/y |
| Net sales - Products · Products · Q3-2026 | $1.22B | -1% y/y |
| Net sales - Services and other · Services and other · Q3-2026 | $272M | +4% y/y |
Risks flagged
Tariff and fuel cost pressure
“incremental cost pressures related to fuel and tariff expense during the thirteen weeks ended August 1, 2026” · word for word
Membership program disruption
“Sales during the thirteen weeks ended August 1, 2026 reflect a temporary disruption from a stronger-than-expected response to our membership program relaunch.” · word for word
Store count decline
“Total pet care centers (U.S.) at end of period 1,377 1,388” · word for word
2 Sep 20268-K · 2.02, 7.01Q2 2026 net sales $1.5B (+0.05% YoY), comparable sales +0.6%, adjusted EBITDA $122.2M (vs $113.9M). Net income $38.7M (vs $14.0M). Reaffirmed FY2026 outlook. $75M debt prepaid.open
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.50B | +0% y/y |
| Comparable sales · Q2-2026 | 0.6% | |
| Gross profit · Q2-2026 | $591M | +1% y/y |
| Gross margin rate · Q2-2026 | 39.7% | |
| Operating income · Q2-2026 | $48M | +11% y/y |
| Net income · Q2-2026 | $39M | +176% y/y |
| Adjusted EBITDA · Q2-2026 | $122M | +7% y/y |
| Cash, cash equivalents and restricted cash · Q2-2026 | $294M | +56% y/y |
| Total debt · Q2-2026 | $1.48B | -7% y/y |
Guidance
FY2026 net sales flat to +1.5%, adjusted EBITDA $415M-$430M
FY2026 outlook reaffirmed; Q3 guidance provided with modest growth expectations.
Risks flagged
Sales disruption from membership program relaunch; initial stronger-than-expected points redemption.
“Sales disruption from the initial stronger-than-expected points redemption from our membership program relaunch” · word for word
Dependence on tariff refunds for margin improvement; normalized gross margin flat YoY.
“Without the net benefit from the tariff refund, normalized gross margin was about flat with the prior year” · word for word
Ongoing supply chain headwinds and tariff exposure.
“Absorbing ongoing supply chain headwinds; tariff refunds net benefit $6.8M”
1 Jul 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Potential dilution from increased authorized shares under equity incentive plan.
“Increase of 15.5 million shares of Class A common stock reserved for issuance under the 2021 Plan.”
5 Jun 202610-QNet sales $1.50B (+0% y/y); Comparable sales change 0.7; Adjusted EBITDA $97M (+9% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $1.50B | +0% y/y |
| Comparable sales change · Q1-2026 | 0.7% | |
| Adjusted EBITDA · Q1-2026 | $97M | +9% y/y |
| Gross profit rate · Q1-2026 | 38.4% | |
| Free Cash Flow · Q1-2026 | $-69M | -58% y/y |
| Services and other revenue · Services and other · Q1-2026 | $269M | +7% y/y |
| Consumables revenue · Consumables · Q1-2026 | $747M | -0% y/y |
| Supplies and companion animals revenue · Supplies and companion animals · Q1-2026 | $481M | -3% y/y |
| Total pet care centers (U.S.) · Q1-2026 | 1,378 | -1% y/y |
Risks flagged
Negative Free Cash Flow
“Free Cash Flow $(69,122) vs $(43,866)”
Inventory Build
“The decrease in operating cash flows were primarily driven by a increase in inventory purchases as well as timing of invoice payments.” · word for word
High Debt and Refinancing
“Loss on extinguishment and modification of debt $11.8 million; refinancing of term loan and issuance of $600M senior secured notes.” · word for word
3 Jun 20268-K · 2.02, 7.01Net Sales $1.50B (+0% y/y); Comparable Sales 0.7; Gross Profit $574M; Guidance: Full-year net sales flat to up 1.5%; adjusted EBITDA $415-430M; Q2 net sales up ~0.3%.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $1.50B | +0% y/y |
| Comparable Sales · Q1-2026 | 0.7% | |
| Gross Profit · Q1-2026 | $574M | |
| Gross Margin · Q1-2026 | 38.4% | |
| Operating Income · Q1-2026 | $25M | +51% y/y |
| Adjusted EBITDA · Q1-2026 | $97M | +9% y/y |
| Net Loss · Q1-2026 | $-15M | |
| Total Debt · Q1-2026 | $1.48B | -7% y/y |
| Free Cash Flow · Q1-2026 | $-69M |
Guidance
Full-year net sales flat to up 1.5%; adjusted EBITDA $415-430M; Q2 net sales up ~0.3%.
Reaffirmed full-year outlook; Q1 results exceeded expectations; positive comp growth validates strategy.
Risks flagged
Free cash flow negative and worsening year-over-year; net loss increased.
“Free cash flow outflow of $69.1M vs $43.9M prior year; net loss of $15.1M vs $11.7M.”
Tariff and fuel cost uncertainties; partial tariff refund received but no additional assumed.
“Outlook assumes current tariff levels and elevated fuel prices; partial IEEPA tariff refund received in May 2026, no additional refunds assumed.”
14 May 2026DEF 14APetco filed its proxy statement, disclosing executive compensation structure, incentive plan metrics, and a proposal to increase equity plan shares.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $5.96B | |
| Adjusted EBITDA · FY2025 | $428M | |
| Adjusted Free Cash Flow · FY2025 | $187M | |
| Net Income · FY2025 | $9M | |
| Total Shareholder Return · FY2025 | $10.33 |
13 Mar 202610-KGoodwill Impairment Charge $1.22B; ABL Revolving Credit Facility Unused Commitments $468M; Principal Stockholder Voting Power 65open
Figures in the filing · each found in the filing text
| Goodwill Impairment Charge · Q3 FY2023 | $1.22B | |
| ABL Revolving Credit Facility Unused Commitments · 2026-01-31 | $468M | |
| Principal Stockholder Voting Power · 2026-03-13 | 65.0% |
Risks flagged
11 Mar 20268-K · 2.02, 7.01Net sales $6.00B (-2% y/y); Comparable sales -1.6; Gross profit $2.30B (-1% y/y); Guidance: FY2026 Adj. EBITDA $415M-$430M, net sales flat to +1.5%earningsopen
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $6.00B | -3% y/y |
| Comparable sales · FY2025 | -1.6% | |
| Gross profit · FY2025 | $2.30B | -1% y/y |
| Gross margin · FY2025 | 38.7% | |
| Operating income · FY2025 | $120M | +1596% y/y |
| Net income · FY2025 | $9M | |
| Adjusted EBITDA · FY2025 | $408M | +21% y/y |
| Free cash flow · FY2025 | $187M | +276% y/y |
| Cash from operations · FY2025 | $314M | +77% y/y |
| Total secured debt · FY2025 | $1.50B | -6% y/y |
Guidance
FY2026 Adj. EBITDA $415M-$430M, net sales flat to +1.5%
FY2026 guidance implies return to positive comparable sales and continued margin expansion, with capex increasing to ~$140M for growth investments.
Risks flagged
Sales decline continues; comparable sales -1.6% for FY2025.
“Net sales decreased 2.5%; comparable sales decreased 1.6%.”
Tariff and fuel price assumptions in guidance could be disrupted.
“Assumptions include that current or planned tariffs on imports into the U.S. from other countries remain at March 11, 2026 levels and fuel prices normalize.”
2 Feb 20268-K · 1.01, 2.03Petco entered into a $900M term loan refinancing and issued $600M in 8.250% senior secured notes due 2031 to repay existing term loan facility. The amendment increases leverage but extends maturities.open
Figures in the filing · each found in the filing text
| aggregate principal amount of term loans · point_in_time | $900M | |
| aggregate principal amount of senior secured notes · point_in_time | $600M |
2 Feb 20268-K · 5.02, 7.01Lump sum payment $9,615.38open
Figures in the filing · each found in the filing text
| lump sum payment · point_in_time | $9615.38 |
23 Jan 20268-K · 7.01Principal amount of notes $600Mopen
Figures in the filing · each found in the filing text
| Principal amount of notes | $600M |
Risks flagged
High coupon rate (8.250%) indicates elevated credit risk; refinancing may increase leverage.
“8.250% senior secured notes due 2031.” · word for word
21 Jan 20268-K · 7.01Senior secured notes principal amount $650Mopen
Figures in the filing · each found in the filing text
| Senior secured notes principal amount · point_in_time | $650M |
Risks flagged
Increased leverage from new notes; secured debt structure may subordinate existing unsecured creditors.
“The notes will be secured on a first-lien priority basis by security interests granted in Petco’s and the guarantors’ fixed assets and on a second-lien priority basis by security interests granted in Petco’s and the guarantors’ current assets.”
12 Jan 20268-K · 7.01Adjusted EBITDA $396M; Guidance: FY2025 Net Sales down 2.5-2.8%, Adjusted EBITDA $395-$397M; Q4 Net Sales down low single digits, Adjusted EBITDA $93-$95Mopen
Figures in the filing · each found in the filing text
| Adjusted EBITDA · FY2025 | $396M |
Guidance
FY2025 Net Sales down 2.5-2.8%, Adjusted EBITDA $395-$397M; Q4 Net Sales down low single digits, Adjusted EBITDA $93-$95M
Petco reaffirms guidance with sales decline but stable EBITDA; debt refinancing aims to improve balance sheet.
Risks flagged
Debt refinancing subject to market conditions; may not be completed.
“Petco intends to refinance $1.5 billion of its current term loan outstanding subject to market and other conditions and therefore can provide no assurances that it will complete the refinancing” · word for word
Sales decline reflects consumer demand pressure and tariff risks.
“Net Sales Down 2.5% - 2.8%... assumptions include that... current or planned tariffs on imports into the U.S. from other countries remain at January 12, 2026 levels” · word for word
5 Dec 202510-QPetco reported Q3 2025 results with net sales down 3.1% YoY but gross margin expansion and positive net income, without explicit beat/miss vs expectations.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $1.46B | -3% y/y |
| Comparable sales change · Q3-2025 | -2.2% | |
| Adjusted EBITDA · Q3-2025 | $99M | +21% y/y |
| Net income (loss) attributable to Class A and B-1 common stockholders · Q3-2025 | $9M | |
| Free Cash Flow · 39 weeks ended 2 | $71M | |
| Operating cash flow · 39 weeks ended 2 | $161M | +97% y/y |
| Gross profit rate · Q3-2025 | 38.9% |
Risks flagged
Continued sales decline risk
“Net sales decreased $47.0 million, or 3.1%, to $1.46 billion in the thirteen weeks ended November 1, 2025 compared to net sales of $1.51 billion in the thirteen weeks ended November 2, 2024.” · word for word
Store count reduction risk
“Total pet care centers (U.S. and Puerto Rico) at end of period 1,389 compared to 1,413 in prior year.” · word for word
25 Nov 20258-K · 2.02, 7.01Net sales $1.50B (-3% y/y); Comparable sales -2.2; Gross profit margin 38.9; Guidance: FY2025 adjusted EBITDA midpoint raised by $6M to $395-397M; Q4 adjusted EBITDA $93-95M.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $1.50B | -3% y/y |
| Comparable sales · Q3-2025 | -2.2% | |
| Gross profit margin · Q3-2025 | 38.9% | |
| Operating income · Q3-2025 | $29M | |
| GAAP net income · Q3-2025 | $9M | |
| Adjusted EBITDA · Q3-2025 | $99M | |
| Adjusted EBITDA guidance (FY2025) · FY2025 | $396M | |
| Net interest expense guidance (FY2025) · FY2025 | $125M | |
| Depreciation & Amortization guidance (FY2025) · FY2025 | $200M | |
| Net store closures guidance (FY2025) · FY2025 | 20 |
Guidance
FY2025 adjusted EBITDA midpoint raised by $6M to $395-397M; Q4 adjusted EBITDA $93-95M.
Guidance raised on profitability despite sales decline; margin expansion driven by cost actions.
Risks flagged
Sales decline and store closures indicate ongoing transformation risk; tariff exposure noted in outlook assumptions.
“Net sales down 3.1% YoY; net store closures ~20; outlook assumes tariffs remain at current levels.”
Petco Health and Wellness Company, Inc. — questions
- What did Petco Health and Wellness Company, Inc. file recently?
- 17 SEC filings in the last 12 months. Latest: 10-Q on 2026-09-04 — Q3 FY2026 results: net sales flat, comparable sales +0.6%, net income up 177%, adjusted EBITDA +7.3%.
Every figure on this page comes from Petco Health and Wellness Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.